Latest News and Press Releases

HORSHOLM, Denmark, May 16, 2002 (PRIMEZONE) -- The Board of Directors in Pharmexa propose that Executive Vice President of Research and Development in H. Lundbeck, Claus Braestrup is elected new...

HORSHOLM, Denmark, May 15, 2002 (PRIMEZONE) -- Pharmexa and ZYCOS today jointly announced that they have entered into an agreement to formulate Pharmexa's therapeutic DNA breast cancer vaccine in...

HORSHOLM, Denmark, April 24, 2002 (PRIMEZONE) -- Pharmexa's 83.3% owned subsidiary Inoxell A/S today announced that the European Patent Office has issued an acceptance of Inoxell's patent on its...

HORSHOLM, Denmark, April 12, 2002 (PRIMEZONE) -- In June 2001 Pharmexa announced that it had in-licensed a vector-cell production system from GlaxoSmithKline (NYSE:GSK) for use in Pharmexa's...

BARCELONA, Spain, March 20, 2002 (PRIMEZONE) -- Dr. Dana Leach, Vice President of Preclinical Development and Immunopharmacology at Pharmexa, today presented the company's HER-2 DNA AutoVac(tm)...

HORSHOLM, Denmark, March 15, 2002 (PRIMEZONE) -- Pharmexa Group's Board of Directors, in a meeting today, approved the audited financial statements for the financial year 2001. The Pharmexa Group...

HORSHOLM, Denmark, March 14, 2002 (PRIMEZONE) -- Pharmexa today announced the appointment of David Gee as Director of Licensing. David joins Pharmexa to manage the out-licensing activities of the...